Kimberly Lynn Blackwell, MD

Adjunct Professor in the Department of Medicine
Member of the Duke Cancer Institute
Campus mail Duke Box 3893, Durham, NC 27710
Phone (919) 668-1748
Email address black034@mc.duke.edu

Breast cancer angiogenesis
Breast cancer in younger women
Hormonal therapy
Neoadjurant therapy for breast cancer

Current Clinical Investigations

Principal Investigator, A Phase I-II Study of Neoadjuvant Evacet/Paclitaxel/Hyperthermia in Locally Advanced Breast Cancer Patients.

Investigator, Development of Screening Markers for Breast Cancer using Circulating Immune Complexes: Collaborative Study with Diagen Medical Technologies.

Principal Investigator, Use of Plasma D-Dimer as a Predictive Marker in Colorectal Carcinoma: Correlative Science Study with Genentech, Inc.

Principal Investigator, A randomized, Phase II study of gabapentin or glutamine to prevent the peripheral neuropathy/myalgia associated with weekly taxol administration in metastatic breast and lung cancer.

Investigator, A Phase 2, Randomized, Double-Masked, Multicenter Study of Two Dose Levels of ERA-923 for the treatment of Metastatic Breast Cancer in Postmenopausal Women who have failed Tamoxifen therapy. Genetics Institute.

Investigator, A Phase I Study of Combined Doxil/Hyperthermia in Stage IV Breast Cancer.

Education and Training

  • Fellow in Hematology-Oncology, Medicine, Duke University, 1997 - 2000
  • Medical Resident, Medicine, Duke University, 1994 - 1997
  • M.D., Mayo School of Health Sciences, 1994

Publications

Demark-Wahnefried, W., B. L. Peterson, E. P. Winer, L. Marks, N. Aziz, P. K. Marcom, K. Blackwell, and B. K. Rimer. “Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy..” J Clin Oncol 19, no. 9 (May 1, 2001): 2381–89. https://doi.org/10.1200/JCO.2001.19.9.2381.

PMID
11331316
Full Text

Blackwell, K. L., Z. A. Haroon, S. Shan, W. Saito, G. Broadwater, C. S. Greenberg, and M. W. Dewhirst. “Tamoxifen inhibits angiogenesis in estrogen receptor-negative animal models..” Clin Cancer Res 6, no. 11 (November 2000): 4359–64.

PMID
11106254
Scholars@Duke

Blackwell, K., Z. Haroon, G. Broadwater, D. Berry, L. Harris, J. D. Iglehart, M. Dewhirst, and C. Greenberg. “Plasma D-dimer levels in operable breast cancer patients correlate with clinical stage and axillary lymph node status..” J Clin Oncol 18, no. 3 (February 2000): 600–608. https://doi.org/10.1200/JCO.2000.18.3.600.

PMID
10653875
Full Text

Blackwell, K. L., D. G. Bostwick, R. P. Myers, H. Zincke, and J. E. Oesterling. “Combining prostate specific antigen with cancer and gland volume to predict more reliably pathological stage: the influence of prostate specific antigen cancer density..” J Urol 151, no. 6 (June 1994): 1565–70.

PMID
7514689
Scholars@Duke

Sandok, B. A., R. R. Orford, and K. L. Blackwell. “A clinical experience in social medicine/cultural diversity..” Acad Med 69, no. 5 (May 1994): 410–11.

PMID
8086051
Scholars@Duke

Secord, A. A., R. Sayer, S. A. Snyder, G. Broadwater, G. C. Rodriguez, A. Berchuck, and K. Blackwell. “Second-look laparotomy in ovarian cancer.” Gynecologic Oncology 55, no. 3 (January 1, 1994): S122–27. https://doi.org/10.1006/gyno.1994.1350.

Full Text

Pages